Skip to content

Clinical verification of diagnostic criteria for syndrome of intermingled phlegm and blood stasis in patients with coronary atherosclerotic heart disease

Clinical verification of diagnostic criteria for syndrome of intermingled phlegm and blood stasis in patients with coronary atherosclerotic heart disease

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900023048
Enrollment
Unknown
Registered
2019-05-08
Start date
2019-06-01
Completion date
Unknown
Last updated
2019-08-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary atherosclerotic heart disease

Interventions

of&#32
Intermingled&#32
Phlegm&#32
and&#32
Blood&#32
Stasis&#32
in&#32
Patients&#32
with&#32
Index test:&#39
Clinical&#32
Diagnostic&#32
on&#32
&#32
Gold Standard:The diagnosis on syndrome of intermingled phlegm and blood stasis in patients with coronary atherosclerotic heart disease was made by two deputy directors and above doctors according to
Atherosclerotic&#32

Sponsors

Institute of Basic Theory of Chinese Medicine, China Academy of Chinese Medicine Science
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Aged 35 to 85 years; (2) Patients with coronary heart disease (we should have the diagnostic basis of coronary heart disease: for example, at least one coronary artery stenosis (> 50%) confirmed by coronary angiography, or confirmed by coronary CTA, or old history of myocardial infarction, or pathological Q wave of ECG, or supported by electrocardiogram stress test and radionuclide examination); (3)Patients with stable coronary heart disease((Occult Coronary Heart Disease, Stable Angina Pectoris or Acute Coronary Syndrome over a Month) (4) Sign the informed consent and volunteer to participate in the research.

Exclusion criteria

Exclusion criteria: (1) Patients with infection, fever, trauma, burns, surgical history or active tuberculosis or rheumatic immune disease in the past week; (2) Patients with acute exacerbation of chronic obstructive pulmonary disease or pulmonary heart disease or respiratory failure; (3) Patients with acute and subacute cerebrovascular diseases; (4) Severe primary diseases such as hematopoietic system or malignant tumors; (5) Organ transplantation patients; (6) Severe mental disorders (sensory disorders, thinking disorders); (7) Those with difficulty in language expression or poor comprehension; (8) Pregnant women and lactating women; (9) Researchers believe that there are other situations that are not suitable for this study.

Design outcomes

Primary

MeasureTime frame
Four Diagnostic Information on syndrome of intermingled phlegm and blood stasis in patients with coronary atherosclerotic heart disease;Expert Syndrome Differentiation Information;

Secondary

MeasureTime frame
Basic information of patients;Disease-related information;Medication situation;

Countries

China

Contacts

Public ContactHu Jingqing

Institute of Basic Theory of Chinese Medicine, China Academy of Chinese Medicine Science

gcp306@126.com+86 13911546633

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026